Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Zach Gibson/Getty Images
Congress' final opioids legislation will expand Medicaid coverage for addiction treatment and will not include a Medicare provision the pharmaceutical industry has lobbied for, according to Modern Healthcare's Susannah Luthi.
The details: Per Modern Healthcare, the House and Senate have agreed to lift the so-called "IMD exclusion" in their final opioids package, which will allow federal Medicaid money to flow to more treatment centers.
- The bill will include Sen. Rob Portman's relatively expansive proposal, lifting the exclusion not just for opioid abuse but for all forms of addiction.
The pharmaceutical industry lost its push to include changes to the Medicare program, perhaps as part of a compromise on drug prices.
- Earlier this year, Congress voted to put the pharmaceutical industry on the hook for more of the costs seniors incur when they fall into Medicare's "donut hole." Drugmakers had been aggressively lobbying lawmakers to reverse that policy as part of the opioids bill.
- Democrats blocked the measure, Modern Healthcare reports, but it will likely come back up as a standalone bill later this year.